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Histamine regulates a variety of physiological proc-
esses including inflammation, gastric acid secretion,
and neurotransmission. The cellular response to hista-
mine is subject to dynamic control, and exaggerated
histamine reactivity in response to cysteinyl leuko-
trienes and other stimuli is important in a variety of
different pathological conditions. The molecular mech-
anisms controlling histamine responsiveness are still
unresolved. In investigating histamine responses in em-
bryonic stem (ES5) and F9 embryonic carcinoma cells,
we encountered a novel mechanism controlling the cel-
lular reaction to histamine. Unstimulated cells dis-
played neither [3H]pyrilamine binding nor histamine-
induced increases in cytosolic Ca21 levels. Pretreatment
of these cells, however, with leukotriene D4, leukotriene
E4, serotonin, or fetal calf serum induced an immediate
and transient ability of these cells to respond to hista-
mine with an increase in cytosolic Ca21 levels. This ef-
fect could be inhibited by pertussis toxin and was mim-
icked by GTP analogues. Importantly, the latter
compounds also provoked immediate high affinity
[3H]pyrilamine binding. We conclude that in these cells
histamine responsiveness is directly controlled by per-
tussis toxin-sensitive G protein-coupled receptors,
whose activation enables the H1 receptor to bind its
ligand. These findings define a novel mechanism for
regulating histamine H1 receptor activity and provide
for the first time molecular insight into the mechanism
by which cysteinyl leukotrienes and other external stim-
uli can increase histamine responsiveness.
Histamine, a biogenic amine formed by decarboxylation of
the amino acid L-histidine (1), is found in large quantities in
most tissues, mainly in the granules of mast cells, although
numerous other cell types are capable of histamine synthesis as
well (2). Histamine controls a multitude of physiological func-
tions by activating specific receptors on target cells. Three
types of receptors for histamine have been described, denomi-
nated as the H1, H2, and H3 receptor and are distinguished on
the basis of their sensitivity to specific agonists and antago-
nists (3). In general, the H3 receptor is implicated in autoinhi-
bition of histamine synthesis and release and the H2 receptor
in gastric acid secretion, whereas the H1 receptor is involved in
inflammatory responses, mediating for instance blood vessel
and bronchial constriction, vascular permeabilization, and syn-
thesis of other inflammatory agents (4). Histamine receptors
are subject to dynamic regulation, receptor activity being in-
creased or diminished in response to various conditions (5–7),
and exaggerated histamine reactivity is associated with a va-
riety of pathological disorders.
Cysteinyl leukotrienes have been implicated in the stimula-
tion of histamine reactivity. Inhalational challenge with these
inflammatory eicosanoids increases histamine responsiveness
of the airways (8–12), and cysteinyl leukotriene-induced hista-
mine hypersensitivity is presumed to be important in asth-
matic disease (13). Also, other signaling molecules stimulate
histamine responsiveness. Especially serotonin, platelet-acti-
vating factor, and thromboxanes are known to enhance hista-
mine reactivity (14, 15). The molecular mechanisms, however,
by which such stimuli can provoke increased histamine respon-
siveness have remained obscure.
In the present study we describe a molecular mechanism by
which external stimuli can enhance histamine reactivity by
directly controlling the affinity of the histamine H1 receptor for
its ligand. We have reported earlier that the P19 embryo car-
cinoma (EC)1 cell, a pluripotent cell type resembling the inner
cell mass of the embryo, expresses functional histamine H1
receptors (16), although its function with respect to embryo-
genesis is not clear. To obtain more insight into the function of
histamine receptor expression in uncommitted cells, we de-
cided to investigate the presence of cellular responses to hista-
mine in other pluripotent cells. We observed that F9 EC cells
and embryonic stem (ES5) cells displayed neither high affinity
[3H]pyrilamine binding nor histamine-induced increases in cy-
tosolic Ca21 levels. A pretreatment of these cells with cysteinyl
leukotrienes, serotonin, or FCS, however, induced an immedi-
ate and transient ability of these cells to react to histamine.
This effect was inhibited by pertussis toxin and was mimicked
by GTP analogues. Importantly, induction of histamine re-
sponses coincided with the appearance of high affinity
[3H]pyrilamine binding sites on these cells. Apparently pertus-
sis toxin-activating agents can regulate histamine responses by
inducing high-affinity binding sites for histamine. These find-
ings define for the first time a molecular mechanism by which
cysteinyl leukotrienes and other external stimuli can increase
histamine responsiveness and identify a novel mechanism for
the regulation of G protein-coupled receptors.
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EXPERIMENTAL PROCEDURES
Chemicals—Histamine dihydrochloride, pyrilamine (maleate salt),
leukotrienes, serotonin, and valinomycin were obtained from Sigma.
Fura-2 acetoxymethyl ester was from Molecular Probes (Eugene, OR),
streptolysin O was from Wellcome Diagnostics (Dartford, UK), GTPgS
was from Boehringer Mannheim, okadaic acid was from Life Technol-
ogies, Inc., and [pyridinyl-5-3H]pyrilamine ([3H]pyrilamine) was from
Amersham (Buckinghamshire, UK). The enantiomers of cicletanine
were kind gifts from the Henri Beaufour Institute-IPSEN Laboratories,
France. SH-FCS was prepared at our laboratory by DTT treatment of
fetal calf serum. DTT hydrolyzes the protein S–S bridges and thereby
inactivates most of the polypeptide growth factors in FCS. The thus-
treated serum is dialyzed to remove traces of DTT.
Cell Culture—F9 EC and P19 EC cells were cultured at 7.5% CO2 and
37 °C in bicarbonate-buffered DF-medium supplemented with 7.5%
FCS. ES5 and D3 ES cells were maintained in conditioned minimal
essential medium (Life Technologies, Inc.) supplemented with 1024 M
b-mercaptoethanol and 20% FCS. The cells were passaged three times
a week using EDTA (0.2 mg/ml) for F9 EC and trypsin (0.05%), EDTA
(0.2 mg/ml) for P19 EC and the ES cell lines. Two days before experi-
mentation the cells were plated to yield subconfluent cultures for
experiments.
Ca21 Determinations—For Ca21 measurements, cells were main-
tained in serum-free medium for 1 h and subsequently loaded with 10
mM Fura-2 acetoxymethylester for 30–45 min at 33 °C in a Hepes-
buffered saline of the following composition: 140 mM NaCl, 5 mM KCl, 1
mM MgCl2, 2 mM CaCl2, 10 mM Hepes, 10 mM glucose, 0.2% bovine
serum albumin adjusted to pH 7.3 with NaOH. During experiments,
cells were maintained in Hepes-buffered saline at 33 °C. For experi-
ments with NaF and AlCl3, use was made of a saline containing 120 mM
NaCl, 20 mM NaF, 75 mM AlCl3, 5 mM KCl, 2 mM CaCl2, 10 mM Hepes,
and 10 mM glucose, pH 7.3. The measurements were carried out with a
fluorescence microscope focusing on a group of 8–12 cells with a 50 3
water immersion objective and a SPEX dual-wavelength fluorimeter.
Emission fluorescence was digitally sampled at 340 and 380 nM and
corrected for background fluorescence as determined from unlabeled
cells. The intracellular Ca21 concentration was calculated according to
Grynkiewicz et al. (17). For digital image analysis, pictures were taken
from a video recording of Fura-loaded cells (excited at 340/380 nM) and
processed with the Crystal Particle Package Version 1.08 (Quantel).
Electrophysiology—For whole-cell patch clamp analysis, cells were
measured in a saline solution of the following composition: 140 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM Hepes, 10 mM glucose
adjusted to pH 7.3 with NaOH. During experiments, cells were main-
tained at 33 °C.The patch pipette contained 140 mM KCl, 2 mM MgCl2,
1 mM CaCl2, 10 mM EGTA, 10 mM Hepes adjusted to pH 7.1 with KOH.
Using the fluorimetric method described by Civitelli et al. (18), we
determined a resting membrane potential for the F9 EC cells of 251
mV, and cells were clamped at this potential. Currents were analyzed
as described earlier (19).
[3H]Pyrilamine Binding—Scatchard analysis on membrane prepara-
tions and intact cells was performed as described earlier (16). For
Scatchard analysis, cells were serum-starved for 1 h, after which they
were labeled for 1 h at 4 °C in Hepes-buffered Dulbecco’s modified
Eagle’s medium containing 4 nM [3H]pyrilamine and different concen-
trations of unlabeled pyrilamine, after which total binding reached
plateau phase (not shown). Subsequently, cells were washed three
times with phosphate-buffered saline, and cell protein was precipitated
with 0.2 M NaOH. The bound radioactivity was determined by liquid
scintillation counting. In each experiment, each condition was tested in
triplicate. For experiments with NaF (20 mM) and AlCl3 (75 mM), the
same buffer was used as described for Ca21 determinations and applied
for 20 min at room temperature, after which the cells were placed on ice
and the [3H]pyrilamine binding assay was performed. For experiments
with GTPgS, cells were first permeabilized for 5–10 min at 37 °C with
0.5 IU/ml streptolysin O in 100 mM KCl, 5.6 mM glucose, 1 mg/ml bovine
serum albumin, 1.3 mM CaCl2, 2 mM EGTA, 0.1 mM MgCl2, 1 mM ATP,
10 mM Hepes, pH 7.2 (20) and washed once in the absence of strepto-
lysin O. GTPgS was added to the permeabilized cells and incubated
shortly (1–2 min) at room temperature to allow GTPgS to enter and
sensitize the cells. Thereafter cells were placed on ice and labeled as
described above. For permeabilized cells, the incubation buffer con-
tained 150 mM KCl, 5 mM NaCl, 5.6 mM glucose, 1 mg/ml bovine serum
albumin, 1 mM ATP, 1.3 mM CaCl2, 0.1 mM MgCl2, 2 mM EGTA, 10 mM
Hepes, pH 7.2.
In general, Scatchard plots made using intact cells show considerable
nonspecific low affinity binding of [3H]pyrilamine (16), more so in per-
meabilized cells when compared with nonpermeabilized cells. There-
fore, Scatchard plots were fitted according to a one- or two-site model,
using the formula, bound/free 5 0.5 ([Bmax1 2 bound]/Kd1 1 [Bmax2 2
bound]/Kd2) 1 0.5 ([{Bmax1 2 bound}/Kd1 1 {Bmax2 2 bound}/Kd2]
2 1 4
[{B
max1
Bmax2}/Kd1 Kd2}]), in which Bmax1, Bmax2, Kd1, and Kd2 are the
respective maximal binding capacities and dissociation constants of the
different affinities. The observed points of the Scatchard plot of un-
stimulated cells were satisfactorily fit with a one-site (low affinity)
model, whereas two affinity binding sites could be distinguished in the
sensitized cells. To determine best fit, we calculated the x2 distribution
of the estimated curve relative to the observed values. We accepted the
fit if the x2 did not exceed the probability value of 5%.
RESULTS
Induction of Histamine Signal Transduction in F9 EC and
D3 ES Cells—Different EC and ES cell lines showed marked
differences in their reaction toward histamine (1 mM). P19 EC
cells and ES5 cells responded to histamine with a marked
increase in cytosolic Ca21 levels and transmembrane currents,
as assayed with whole-cell patch clamp electrophysiology and
fluorimetric Ca21 determinations (Figs. 1 and 2). Such re-
sponses, however, were absent in the F9 EC and D3 ES cells
(Figs. 1 and 2; Tables I and II). Even digital image analysis
(which allows detection of small responses in single cells) of
Fura-2-loaded F9 EC and ES5 cells did not reveal any response
to histamine in these cells (Fig. 3). Importantly, we noted that
stimulation of F9 EC and D3 ES cells with 5% (DTT-treated)
fetal calf serum (SH-FCS), 1 mM leukotriene D4, 1 mM leukotri-
ene E4, or 3 mM serotonin induced an ability in these cells to
respond to histamine: after prestimulation with one of these
compounds, both histamine-induced Ca21 responses and trans-
membrane currents were easily detected (Figs. 1–3; Tables I
and II). Control experiments consistently showed that F9 EC
and D3 ES cells spontaneously reacted toward ATP (50 mM) and
bradykinin (1 mM) but never did show uninduced histamine
responses (n 5 29). Furthermore, ATP and bradykinin were not
able to induce histamine responsiveness. We were confident,
therefore, to have encountered a novel form of regulation of
histamine responsiveness, as the cellular reaction to histamine
in the F9 EC and D3 ES lines requires sensitization by specific
stimuli.
Histamine Responsiveness Induced by SH-FCS Is Transient
FIG. 1. The effect of histamine (HA)
on the intracellular Ca21 concentra-
tion in P19 EC and F9 EC cells. Rep-
resentative traces of the intracellular
Ca21 concentration of Fura-2-loaded P19
EC (A) and F9 EC (B and C) are shown.
The additions of the stimuli are indicated.
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and Is Mediated by the H1 Receptor—To further characterize
the induction of histamine responsiveness, we performed fluo-
rimetric Ca21 determinations in the F9 EC cell line using
SH-FCS as a pre-stimulus. The induction of histamine respon-
siveness by SH-FCS is fast, as coapplication of SH-FCS and
histamine had a supra-additive effect. The SH-FCS-induced
responsiveness, however, is of a highly transient nature. Al-
ready, 10 min after application of serum, the sensitivity of
these cells to histamine was lost (Fig. 4). Pharmacological
studies carried out after induction of histamine responsiveness
with 5% SH-FCS showed that the reaction to histamine in
these cells was inhibited by the H1 receptor antagonists pyril-
amine (1 mM) and (2)cicletanine (15 mM) but not by the H1-
unspecific enantiomer (1)cicletanine (15 mM). Apparently, SH-
FCS transiently enables H1 receptor signaling in D3 ES and F9
EC cells. Subsequent experiments were performed to obtain
insight into the mechanisms implicated in the regulation of
this transient histamine H1 receptor responsiveness.
Role of the Ca21 Response in the Induction of Histamine
Responsiveness—Although leukotrienes and serotonin activate
only minor Ca21 fluxes when compared with SH-FCS, hista-
mine-induced Ca21 responses were not different after induc-
tion with either leukotrienes, serotonin, or SH-FCS (Fig. 4B;
Table II). Also, stimulation with FCS, which tends to yield
bigger Ca21 responses when compared with SH-FCS (not
shown), did not produce different Ca21 responses to histamine.
These results suggest that the size of the Ca21 response pro-
duced by the sensitizing stimulus is not indicative of the
FIG. 2. The effect of histamine on transmembrane currents in
embryonal carcinoma cells. Representative whole cell patch clamp
tracings (outward currents down) of P19 EC (A) and F9 EC cells (B and
C) are shown. The additions of the stimuli are indicated (HA 5 0.1 mM
histamine; SH-FCS 5 5% DTT-treated fetal calf serum).
TABLE I
Ca21 determinations
The number of histamine responses is shown (i.e. an increase in
cytosolic Ca21 in excess of 25 nM)/total number of experiments. ND, not
determined.
Condition F9 EC ES5
0.1 mM histamine 0/29 0/12
5% SH-FCS 1 0.1 mM histamine 66/84 20/20
100 ng/ml pertussis toxin 1 5% SH-FCS 1 0.1
mM histamine
0/7 ND
20 mM NaF 1 75 mM AIF3 1 0.1 mM Histamine 10/20 ND
TABLE II
Whole patch clamp experiments in F9 EC cells
The number of histamine responses is shown (i.e. an increase in
transmembrane currents in excess of 10 pA)/total number of experi-
ments and average histamine-induced current 6 standard deviation.
Condition No. ofresponses
Histamine-induced
current
pA
0.1 mM histamine 0/15
5% SH-FCS 1 0.1 mM histamine 9/9 90 6 50
1 mM LTD4 1 0.1 mM histamine 4/4 70 6 10
1 mM LTE4 1 0.1 mM histamine 6/7 80 6 50
3 mM serotonine 1 0.1 mM histamine 4/4 120 6 80
100 ng/ml pertussis toxin 1 5% SH-FCS
1 0.1 mM histamine
0/5
100 ng/ml pertussis toxin 1 1 mM LTE4
1 0.1 mM histamine
0/4
FIG. 3. The effect of histamine on the intracellular Ca21 con-
centration in F9 EC cells. Pseudo-color images of video-recorded
Fura-2/AM-loaded cells. Upper panel, absence of a response to 0.1 mM
histamine (a1, 30 s before histamine addition; a2, 5 s before histamine
addition; a3, 15 s; a4, 30 s; a5, 60 s after histamine addition). Lower
panel, induction of histamine responsiveness by 5% SH-FCS (b1, 30 s
before SH-FCS; b2, 20 s after SH-FCS; b3, 55 s after SH-FCS, 5 s before
histamine addition; b4, 5 s after histamine; b5, 10 s after histamine
addition; b6, 60 s after histamine addition).
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amount of subsequently induced histamine responsiveness. To
test this possibility, we initiated a series of experiments in
which the size of the Ca21 response to SH-FCS was compared
with the Ca21 response to histamine added 60 s later. As shown
in Fig. 4C, no relationship between the two Ca21 responses was
detected. We concluded that the induction of histamine respon-
siveness is independent of the size of the prior Ca21 response
provoked by the sensitizing agent.
Induction of Histamine Responsiveness in F9 EC Cells Re-
quires Pertussis Toxin-sensitive G Proteins—To further inves-
tigate the signal transduction pathways regulating this tran-
sient histamine responsiveness, we observed that an increase
in intracellular Ca21, cAMP analogues or forskolin treatment,
cGMP analogues, inhibitors of phospholipase A2, arachidonic
acid, or the phorbol ester 12-O-tetradecanoylphorbol-13-ace-
tate (acute or overnight treatment) neither induced nor pre-
vented the sensitization of histamine responses in F9 EC cells
(not shown). Because serum, leukotrienes, and serotonin are
potent inducers of membrane hyperpolarization in this cell
type (not shown), we also tested the effect of the K1 ionophore
valinomycin. Although this compound provoked strong hyper-
polarization, no effect on the induction of histamine responsive-
ness was noted in either F9 EC cells or D3 ES cells (not shown).
Treatment with the phosphatase inhibitor okadeic acid pro-
longed histamine responsiveness, suggesting an involvement of
serine/threonine phosphorylation in the induction of histamine
responsiveness (Fig. 4D).
Because in contrast to the H1 receptor (16, 21), serotonin,
leukotriene D4, leukotriene E4, and serum activate pertussis
toxin-sensitive G proteins, we investigated the effect of a 4-h
pretreatment with pertussis toxin (100 ng/ml). It appeared that
the serum-, leukotriene- and serotonin-provoked inductions of
histamine responsiveness were abolished by this procedure (as
determined either by fluorimetric Ca21 determinations or
patch clamp electrophysiology; Tables I and II). Therefore, the
sensitization of the histamine response appears to be depend-
ent on the activation of pertussis toxin-sensitive G protein-
coupled receptors. To test whether activation of G proteins is
sufficient for induction of histamine responsiveness, F9 EC
cells were injected with 10 mM GTPgS. This procedure was
indeed sufficient for inducing histamine responsiveness, as
assayed with whole-cell patch clamp (Fig. 5B), whereas GDPbS
injection did not produce this effect. The GTPgS-induced his-
tamine responsiveness was, however, of a highly transient
FIG. 4. Application of SH-FCS to F9 EC cells yields a transient responsiveness to histamine. A, the kinetics of the response to 5%
SH-FCS followed by 0.1 mM histamine (HA) with increasing time intervals. B, example of a LTE4-induced histamine response as assayed with
whole cell patch clamp. C, relation between the response to histamine and SH-FCS, measured at the peak of the response, with a time interval
of 50–70 s between the subsequent stimuli. D, effect of okadeic acid (oka) on histamine responsiveness induced by SH-FCS as analyzed with
fluorimetric Ca21 determinations.
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nature (Fig. 5C), maybe due to GTPgS-dependent activation of
histamine signaling elements, making further stimulation of
these signaling elements by the receptor impossible. In agree-
ment, impalement of cells with GTPgS-containing pipettes pro-
voked strong currents, indicating activation of such signaling
elements by GTPgS. GTPgS-induced histamine responsiveness
was eliminated by the H1 receptor antagonist pyrilamine (Fig.
6) but not by cimetidine (a H2 receptor antagonist), demon-
strating that this histamine responsiveness is mediated by the
H1 receptor. Treatment of cells with 20 mM NaF and 75 mM
AlCl3 (which potently activates G proteins) led within 5 min
after application to a slow but sustained increase in intracel-
lular Ca21 (Fig. 5A), probably due to activation of Ca21-mobi-
lizing G protein-dependent signaling elements. Importantly,
such a treatment also induced histamine-dependent Ca21 re-
sponses on top of the aforementioned sustained increase in
intracellular Ca21 levels within 20 min after application of
AlF3 (Fig. 5A; Table I). We concluded that activation that
activation of pertussis toxin-sensitive G proteins is implicated
in the induction of histamine responsiveness.
Induction of Histamine Responsiveness Coincides with the
Appearance of High Affinity [3H]Pyrilamine Binding—To fur-
ther explore the processes underlying the induction of hista-
mine responsiveness, Scatchard analysis was performed. Sur-
prisingly, in unstimulated F9 EC cells, no high affinity
[3H]pyrilamine binding was observed (n 5 7; Fig. 7A), in con-
trast to P19 EC cells (which react unconditionally to hista-
mine), which exhibited high affinity binding of [3H]pyrilamine
(kd ' 7 nM; n 5 2). In accordance, whole cell membrane prep-
arations of P19 EC cells displayed high affinity binding of
[3H]pyrilamine, but no such binding could be detected in F9 EC
cells. These results suggest that the failure of F9 EC cells to
react to histamine under uninduced conditions is due to the
absence of high affinity histamine binding activity, and that
induction of histamine responsiveness is caused by a rapid
increase of high affinity histamine binding sites on the plasma
membrane. Indeed, introduction of GTPgS into the cells rapidly
induces [3H]pyrilamine binding with a Kd of 19 6 4 nM and a
Bmax of 0.15 6 0.02 pmol/10
6 cells (6 S.E.; n 5 3; Fig. 7). Also,
treatment of nonpermeabilized cells with 20 mM NaF and 75
mM AlCl3 induces high affinity [
3H]pyrilamine binding with an
apparent Kd of 24 6 3 nM and a Bmax of 0.31 6 0.12 pmol/10
6
cells (n 5 4; Fig. 7B). As our observations with regard to the
transient nature of the induced histamine responsiveness pre-
dicted a transient induction of [3H]pyrilamine by external sen-
sitizing stimuli like leukotrienes and AlF3, we also tested
whether such transient [3H]pyrilamine binding to cells could be
demonstrated. At 37 °C, these experiments yielded rather vari-
able results, probably because only after 1 h of labeling,
[3H]pyrilamine binding to cells reaches equilibrium, whereas
induction of histamine responsiveness at this temperature by
such stimuli is short-lived. When experiments were performed
at lower temperatures, however, transient induction of [3H]
pyrilamine binding became apparent (Fig. 8). Together our
observations strongly suggest that a pre-stimulus-induced
change in receptor conformation, resulting in a highly in-
creased affinity for histamine, underlies the observed regula-
tion of H1 receptor action in F9 EC cells. Therefore, these
results define a hitherto undescribed mechanism controlling
H1 receptor function.
DISCUSSION
In the present study we show that H1 receptor signaling in
F9 EC cells and ES5 cells required prestimulation of the cells
with either fetal calf serum, serotonin, leukotriene D4, or leu-
kotriene E4, whereas bradykinin and ATP did not produce this
effect. This sensitizing effect was inhibited by pertussis toxin,
whereas it was mimicked by GTPgS and AlF4
2. Therefore, per-
tussis toxin-sensitive G proteins are probably mediating this
regulation of H1 receptor action. The molecular basis for the
induction H1 receptor responsiveness appears to be the appear-
ance of high affinity ligand binding sites, as control cells did not
display high affinity [3H]pyrilamine binding, but introduction
of GTPgS or treatment with AlF4
2 immediately provoked such
high affinity [3H]pyrilamide binding sites. These findings
strongly suggest that histamine responses in these cells are
controlled by agents that induce high affinity binding sites for
histamine and define a molecular mechanism by which exter-
nal stimuli can control histamine H1 receptor action.
The molecular details, however, by which external stimuli
enable the H1 receptor to interact with its ligand, remain
unclear. An explanation for the impaired H1 receptor function
in unstimulated cells may be a physical impossibility for his-
tamine to interact with its receptor. Generally, receptors may
be continuously recycled between plasma membrane and endo-
somes. Although this process has not been reported for H1
receptors, it has been found to occur with several other G
FIG. 5. Induction of histamine responsiveness in F9 EC cells by
AlF4
2 and GTPgS. A shows a representative Ca21 tracing of the
effect of 20 mM NaF and 75 mM AlCl3 on the responsiveness to
histamine (HA) added 6 min later. Pretreatment with NaF and
AlCl3 permitted a Ca
21 response to histamine in 10 out of 20 experi-
ments. B shows the response to 0.1 mM histamine on transmembrane
currents (whole cell patch clamp) when 10 mM GTPgS was included in
the patch pipette solution. Histamine was added 40 s after impalement.
The relation between the response to histamine and the time interval
after impalement is plotted in C.
FIG. 6. Effect of pyrilamine on histamine-induced transmem-
brane currents in GTPgS-injected F9 EC cells. Cells were impaled
with 20 mM GTPgS containing whole cell electrodes for 40 s in the
presence of several concentrations of extracellular pyrilamine and sub-
sequently stimulated with 0.1 mM histamine.
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protein-coupled receptors (e.g. Ref. 22), including the H2 recep-
tor (7), and some of the signaling elements involved have been
identified (e.g. Refs. 23 and 24). It is conceivable that in cell
types that require sensitization for histamine responsiveness,
the balance between endosome and plasma membrane localiza-
tion is shifted to the endosomal state, and that sensitization
releases this shift. Such a scheme would imply that in unstimu-
lated F9 EC and ES5 cells the large majority of histamine
receptors has an endosomal location. In other cells types, how-
ever, which show unconditional histamine responses, the bal-
ance between endosomal and plasma membrane-localized re-
ceptors should be shifted in favor of a plasma membrane
location. In this context it is interesting to note that pertussis
toxin-sensitive G proteins have been implicated in the stimu-
lation of vesicle fusion (e.g. Refs. 25–27) and that rab3-medi-
ated exocytosis from mast cells is pertussis toxin-sensitive (28).
Such a mechanism, however, can not explain the absence of
high affinity binding of [3H]pyrilamine in whole cell membrane
preparations of uninduced F9 EC cells, prompting alternative
explanations for induction of histamine responses in these
cells.
Therefore, control of the histamine response by SH-FCS,
leukotrienes, and serotonin may be mediated by the induction
of a conformational change of the histamine H1 receptor, re-
sulting in increased ligand affinity. Our experiments using the
phosphatase inhibitor okadaic acid in F9 EC cells implicate a
serine/threonine phosphorylation event in the stimulus-
dependent sensitization of the histamine response, opening the
possibility that a phosphorylation of the receptor underlies this
conformational change. In agreement, mutational analysis of
the H2 receptor has shown that relatively small changes in the
intracellular domain can have profound influences on ligand
affinity (7), and the primary sequence of the H1 receptor con-
tains a number of serine and threonine residues that may serve
as potential phosphorylation sites for an affinity controlling
kinase (Yamashita et al. (30)). Such a mechanism would con-
trast the proposed regulation of rhodopsin and the a2-adrener-
gic receptor, where receptor phosphorylation is associated with
deactivation (29). Further biochemical and mutational charac-
terization of the H1 receptor is required to determine whether
specific phosphorylation sites are involved in the regulation of
the receptor affinity and activity.
H1 receptor activation has been implicated in processes like
inflammation and anaphylaxis, and therefore H1 receptor ac-
tion must be carefully regulated. It is to be expected that
mechanisms have evolved for controlling the signaling by the
H1 receptor. The regulation of histamine responsiveness as
described in the present study provides such a control mecha-
nism because for stimulation of the H1 receptor in these cells,
both a pre-stimulus as well as histamine are necessary. Inter-
estingly, in pathological conditions like asthma and allergy,
exaggerated histamine reactivity is associated with the forma-
tion of cysteinyl leukotrienes (13) and serotonin (15), but no
molecular details are known. The findings described in this
study for inducing histamine responsiveness define for the first
time a molecular mechanism by which such control of hista-
FIG. 7. Induction of high affinity [3H]pyrilamine binding sites by GTPgS (A) and AlF4
2 (B). A shows a Scatchard plot representing the
binding of [3H]pyrilamine to streptolysin O (0.5 IU/ml in 100 mM KCl, 5.6 mM glucose, 1 mg/ml bovine serum albumin, 1.3 mM CaCl2, 2 mM EGTA,
0.1 mM MgCl2, 1 mM ATP, 10 mM Hepes, pH 7.2) permeabilized F9 EC cells (open circles) and permeabilized F9 EC cells treated with 20 mM GTPgS
(filled circles). The solid line indicates the induced high affinity binding, whereas the dotted line indicates the constitutive nonspecific low affinity
binding (16). B, displays a Scatchard plot of [3H]pyrilamine binding to unpermeabilized cells (open circles) and to unpermeabilized cells treated
with NaF and AlCl3 (filled circles). The solid line indicates the induced high affinity binding, whereas the dotted line indicates the constitutive
nonspecific low affinity binding. Scatchard analysis and fitting was performed as described earlier (16).
FIG. 8. Transient induction of high affinity [3H]pyrilamine
binding in intact F9 EC cells by sensitizing stimuli. Our observa-
tions with regard to the transient nature of the induced histamine
responsiveness predicted a transient induction of [3H]pyrilamine by
external sensitizing stimuli like leukotrienes and AlF3, without the
need for cell permeabilization. We tested whether such transient
[3H]pyrilamine binding to intact cells could be demonstrated. Cells
incubated with 4 nM [3H]pyrilamine in the presence (filled circles, solid
line) or absence (open circles, dotted line) of the sensitizing agent at 4 °C
for the time periods indicated. To determine high affinity [3H]pyril-
amine binding, the amount of label nondisplaceable with 100 mM cold
pyrilamine was subtracted. Under these conditions, transient induction
of high affinity [3H]pyrilamine binding becomes visible. [3H]Pyrilamine
bound at each time point is the total specifically bound expressed as a
percentage of total unbound and bound at the same time.
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mine reactivity may be exerted, but further studies are re-
quired to assess the importance of this mechanism in these
pathological conditions. These studies are currently under
progress.
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